Life Sciences

Industry Overview

Life Sciences

Accelerating Innovation in an Increasingly Volatile Sector

From early-stage biotechnology start-ups to large multinational pharmaceuticals, the life sciences industry relies on innovation to meet shifting demands in health and improve treatment outcomes around the globe. However, emerging and established risks force organizations to operate in a volatile environment. While navigating research and development challenges, supply chain impacts and barriers to commercial sales, businesses also find themselves swept up in the fight for talent.

Finding new ways to cost-effectively manage risk and attract and retain a digitally-savvy workforce will accelerate innovation to create greater efficiencies, develop personalized medical treatments and access new markets. But with ever-evolving regulation, governance and production interruptions impacting the pace of progress, businesses across this sector must be resilient, investing in end-to-end solutions for their risk and human capital, as well as workforce health and wellbeing to protect vital talent.


Participate in Aon’s 2023 Global Risk Management Survey

Our next Global Risk Management Survey is here. Join in and share your perspective on the most important risks impacting your business, industry, and region. Click the link below to take part and receive a benchmarking report if you complete the survey.

Industry Insights

More Insights
Subscribe CTA Banner